Quarterly report · Q1
2503.TEDINET S100TE18
Period2024-01-01 → 2024-03-31
Filed2024-05-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥501.8bn | 2024-01-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.13T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥450.3bn | 2023-01-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Operating income | ¥30.8bn | 2024-01-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥11.0bn | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥44.2bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥197.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥20.1bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥25.9bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥112.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥5.6bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥32.6bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥11.3bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.00T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥2.87T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.47T | at 2023-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.55T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.44T | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.46T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.43T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.23T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.25T | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.16T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.13T | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥971.9bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥151.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥131.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥116.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.1bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥39.9bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥203.2bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥41.9bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥65.3bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥226.1bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥31.4bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥34.7bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥35.9bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥8.6bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥31.98 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥139.16 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥6.9 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥31.98 | 2024-01-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥139.15 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥6.9 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 38.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.5% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-03-31 | ¥20.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-03-31 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥15.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-03-31 | −¥158m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-03-31 | −¥17.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-03-31 | −¥17.2bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥12.3bn |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥238.6bn |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥238.2bn |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥379m |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥18.4bn |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥32.7bn |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥31.9bn |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥726m |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥1.7bn |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥122.2bn |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥121.5bn |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥645m |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥12.2bn |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥105.6bn |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥105.5bn |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥67m |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-03-31 | ¥22.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-03-31 | ¥6.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥16.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | −¥265m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | −¥18.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | −¥18.0bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥11.5bn |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥225.4bn |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥225.1bn |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥300m |
| jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥20.9bn |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥18.4bn |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥17.4bn |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥991m |
| jpcrp040300-q1r_E00395-000Health Sciencereportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥1.4bn |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥108.6bn |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥108.0bn |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥609m |
| jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥9.6bn |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥93.5bn |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥93.4bn |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥107m |
| jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥16.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 779
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 102218300 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 8101432 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 810143200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 1638500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 914000000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 8101432 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 102218300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 102218300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1118 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 102218300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 102218300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1118 | |
| Property plant and equipment IFRS | Prior1YearInstant | 592928000000 | JPY |
| Property plant and equipment IFRS | CurrentQuarterInstant | 606764000000 | JPY |
| Goodwill IFRS | Prior1YearInstant | 390568000000 | JPY |
| Goodwill IFRS | CurrentQuarterInstant | 442672000000 | JPY |
| Intangible assets IFRS | Prior1YearInstant | 303540000000 | JPY |
| Intangible assets IFRS | CurrentQuarterInstant | 355673000000 | JPY |
| Investments accounted for using equity method IFRS | Prior1YearInstant | 370720000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentQuarterInstant | 368061000000 | JPY |
| Other financial assets nca IFRS | Prior1YearInstant | 105346000000 | JPY |
| Other financial assets nca IFRS | CurrentQuarterInstant | 108585000000 | JPY |
| Other non current assets nca IFRS | Prior1YearInstant | 39340000000 | JPY |
| Other non current assets nca IFRS | CurrentQuarterInstant | 42055000000 | JPY |
| Deferred tax assets IFRS | Prior1YearInstant | 109322000000 | JPY |
| Deferred tax assets IFRS | CurrentQuarterInstant | 102983000000 | JPY |
| Non current assets IFRS | Prior1YearInstant | 1911764000000 | JPY |
| Non current assets IFRS | CurrentQuarterInstant | 2026794000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 330984000000 | JPY |
| Inventories ca IFRS | CurrentQuarterInstant | 353116000000 | JPY |
| Trade and other receivables ca IFRS | Prior1YearInstant | 444940000000 | JPY |
| Trade and other receivables ca IFRS | CurrentQuarterInstant | 403817000000 | JPY |
| Other financial assets ca IFRS | Prior1YearInstant | 8944000000 | JPY |
| Other financial assets ca IFRS | CurrentQuarterInstant | 8938000000 | JPY |
| Other current assets ca IFRS | Prior1YearInstant | 37552000000 | JPY |
| Other current assets ca IFRS | CurrentQuarterInstant | 56755000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 131399000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 151207000000 | JPY |
| Current assets other than assets held for sale ca IFRS | Prior1YearInstant | 953818000000 | JPY |
| Current assets other than assets held for sale ca IFRS | CurrentQuarterInstant | 973832000000 | JPY |
| Assets held for sale IFRS | Prior1YearInstant | 4004000000 | JPY |
| Assets held for sale IFRS | CurrentQuarterInstant | 4073000000 | JPY |
| Current assets IFRS | Prior1YearInstant | 957821000000 | JPY |
| Current assets IFRS | CurrentQuarterInstant | 977905000000 | JPY |
| Assets IFRS | Prior1YearInstant | 2869585000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |